Civilisation Ventures

Venture Capital

Portfolio

companies

Oxford Cancer Analytics

Oxford Cancer Analytics develops blood tests for early cancer detection using proteomics and artificial intelligence.

Seed6 September 2021

£1.3M

Oxford Cancer Analytics raises £1.3m in seed funding to expand its early lung cancer detection platform

The oversubscribed round drew participation from Cancer Research UK, Civilisation Ventures, and various angel investors.

"to shape a future in which early cancer detection becomes the norm rather than the exception"

— Peter Liu, CEO